enforcement database
FDA Form 483 Inspection Citations
215 documented actions on record. FDA Form 483 observations issued after a facility inspection, before any warning letter or recall follows.
- Total actions
- 215
- Earliest on record
- October 22, 2024
- Most recent
- July 17, 2026
- Source
- openFDA (483)
Severity breakdown
- High215
Most recent form 483 inspection citations (30 of 215 shown)
- Cascade Specialty Pharmacy LLC -- FDA 483: 6 observations (2026-07-17)
July 17, 2026·High
- Turbare Manufacturing -- FDA 483: 4 observations (2026-07-07)
July 7, 2026·High
- Annovex Pharma Inc -- FDA 483: 1 observation (2026-07-03)
July 3, 2026·High
- Fayetteville VA Medical Center -- FDA 483: 1 observation (2026-06-15)
June 15, 2026·High
- Denver Solutions LLC dba Leiters Health -- FDA 483: 1 observation (2026-06-08)
June 8, 2026·High
- Lt Col Luke Weather Jr Veterans Affairs Medical Center -- FDA 483: 6 observations (2026-06-04)
June 4, 2026·High
- Sincerus Florida, LLC -- FDA 483: 5 observations (2026-05-29)
May 29, 2026·High
- Strides Pharma Science Limited -- FDA 483: 1 observation (2026-05-20)
May 20, 2026·High
- Emcure Pharmaceuticals Limited -- FDA 483: 1 observation (2026-05-15)
May 15, 2026·High
- Richmond VA Medical Center -- FDA 483: 2 observations (2026-05-12)
May 12, 2026·High
- VA San Diego Healthcare Systems -- FDA 483: 11 observations (2026-05-08)
May 8, 2026·High
- Alvotech Hf -- FDA 483: 1 observation (2026-05-08)
May 8, 2026·High
- Zydus Lifesciences Limited -- FDA 483: 1 observation (2026-05-05)
May 5, 2026·High
- QuVa Pharma Inc -- FDA 483: 3 observations (2026-05-04)
May 4, 2026·High
- Mixlab WI LLC -- FDA 483: 1 observation (2026-05-01)
May 1, 2026·High
- Alkem Laboratories Limited -- FDA 483: 1 observation (2026-05-01)
May 1, 2026·High
- Catalent Indiana LLC -- FDA 483: 8 observations (2026-04-24)
April 24, 2026·High
- Zhejiang Huahai Pharmaceutical Co., Ltd. -- FDA 483: 1 observation (2026-04-24)
April 24, 2026·High
- Cliantha Research Limited -- FDA 483: 1 observation (2026-04-17)
April 17, 2026·High
- Novel Laboratories, Inc. d.b.a Lupin Somerset -- FDA 483: 1 observation (2026-04-17)
April 17, 2026·High
- BPI Labs, LLC -- FDA 483: 1 observation (2026-04-17)
April 17, 2026·High
- Central Alabama Veterans Health Care System -- FDA 483: 2 observations (2026-04-16)
April 16, 2026·High
- Wells Pharma of Houston LLC -- FDA 483: 4 observations (2026-04-13)
April 13, 2026·High
- Wells Pharmacy Inc -- FDA 483: 1 observation (2026-04-09)
April 9, 2026·High
- Pharmaneek Inc -- FDA 483: 3 observations (2026-04-08)
April 8, 2026·High
- Revive Rx LLC -- FDA 483: 5 observations (2026-03-27)
March 27, 2026·High
- Bentley Laboratories LLC -- FDA 483: 1 observation (2026-03-27)
March 27, 2026·High
- Fujifilm Diosynth Biotechnologies USA Inc. -- FDA 483: 1 observation (2026-03-27)
March 27, 2026·High
- Allure Labs, LLC -- FDA 483: 1 observation (2026-03-27)
March 27, 2026·High
- Charles River Laboratories, Inc. DBA Charles River, Endosafe -- FDA 483: 1 observation (2026-03-27)
March 27, 2026·High
Other enforcement types
Sourced from openFDA public enforcement data. Not legal or regulatory advice. Report an error via /contact.